| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/21/2007 | WO2007041439A3 Centrosomal proteins, nucleic acids and method of use thereof |
| 06/21/2007 | WO2007027559A3 Neuroprotective and neurorestorative methods and compositions |
| 06/21/2007 | WO2007020520A3 Antigenic peptides and their use |
| 06/21/2007 | WO2007019575A3 Methods for treating b-cell malignancies using taci-ig fusion molecule |
| 06/21/2007 | WO2007018846A3 Use of interferon- tau for reduction of scar tissue formation |
| 06/21/2007 | WO2007013666A3 Anti-tumor agents comprising r-spondins |
| 06/21/2007 | WO2007011880A3 Enhanced ocular neuroprotection/neurostimulation |
| 06/21/2007 | WO2007011757A8 Use of inhibitors of the ubiquitin proteasome pathway for increasing contractility of the heart |
| 06/21/2007 | WO2007007327A3 Il-32 modulators |
| 06/21/2007 | WO2007002469A3 Therapeutic compositions and methods using transforming growth factor-beta mimics |
| 06/21/2007 | WO2006133931A3 Identification of jak/stat pathway modulating genes by genome wide rnai screening |
| 06/21/2007 | WO2006130666A3 Medicaments and methods combining a hcv protease inhibitor and an akr competitor |
| 06/21/2007 | WO2006119356A3 Splicing-mediated regulation of gene expression |
| 06/21/2007 | WO2006119121A3 Cell-surface decoration with active agents |
| 06/21/2007 | WO2006119035A3 Vegf variants |
| 06/21/2007 | WO2006101782A3 A cysteine-containing peptide tag for site-specific conjugation of proteins |
| 06/21/2007 | WO2006096701A3 Pharmaceutical liposomal compositions |
| 06/21/2007 | WO2006087340A8 Highly potent full and partial agonists and antagonists of the nociceptin/orphanin fq receptor |
| 06/21/2007 | WO2006063168A3 Oxytocin receptor antagonists and their use for the treatment of pulmonary related diseases |
| 06/21/2007 | WO2005046318A3 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders |
| 06/21/2007 | WO2004078135A3 LIGANDS THAT BIND TO THE AMYLOID-β PRECURSOR PEPTIDE AND RELATED MOLECULES AND USES THEREOF |
| 06/21/2007 | WO2003064628A3 Novel proteins and nucleic acids encoding same |
| 06/21/2007 | WO2002100330A9 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES |
| 06/21/2007 | US20070143871 Non-human transgenic animal models for hepatocellular carcinoma |
| 06/21/2007 | US20070142622 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 06/21/2007 | US20070142462 Method of Treating Cancer |
| 06/21/2007 | US20070142392 Uses of rifamycins |
| 06/21/2007 | US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ |
| 06/21/2007 | US20070142316 Antisense IAP oligonucleotides and uses thereof |
| 06/21/2007 | US20070142314 Administering a nucleotide decoy of an ets gene or a chimera decoy of NF-Kappa B with a hydrophillic polymer carrier sheet; aneurysm, Marfan's syndrome, aortic detachment, and plaque rupture |
| 06/21/2007 | US20070142304 Diphenylazetidinone derivatives possessing chloesterol absorption inhibitory activity |
| 06/21/2007 | US20070142303 Buffer intracellular reduction and oxidation for the stressed cells in various disease states; beneficial as adjunctive support therapy, multiple chemical sensitivity syndrome, Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Roussy-Levy syndrome, Rosenberg Chutorian syndrome, Korsakoff syndrome |
| 06/21/2007 | US20070142302 Peptidyl prodrugs that resist p-glycoprotein mediated drug efflux |
| 06/21/2007 | US20070142301 inhibit HCV NS3/NS4a serine protease activity; modulate the processing of hepatitis C virus (HCV) polypeptide |
| 06/21/2007 | US20070142300 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 06/21/2007 | US20070142299 Compositions and methods for regulating apoptosis |
| 06/21/2007 | US20070142298 Tetrapeptide lysyl-glutamyl-aspartyl-tryp-tophane |
| 06/21/2007 | US20070142297 New uses for amino acid anticonvulsants |
| 06/21/2007 | US20070142296 D-amino acid peptides |
| 06/21/2007 | US20070142295 Thrombopoietic compounds |
| 06/21/2007 | US20070142294 Identification and cloning of novel human gene, RET16, involved in the intracellular signaling cascade |
| 06/21/2007 | US20070142293 Controlling gene expression; apoptosis therapy; Continuous infusion; genetically engineered |
| 06/21/2007 | US20070142292 Stimulates production of macrophage inflammatory protein from hepatocytes; metal chelator; inhibits bacterial growth |
| 06/21/2007 | US20070142291 Methods for treating irritable bowel syndrome |
| 06/21/2007 | US20070142290 Surface-modified serum albumin-metal porphyrin composite, and oxygen infusion solution containing the same |
| 06/21/2007 | US20070142289 Use of insulin-like growth factor binding protein 3 (IGF-BP3) for inhibition of tumor growth |
| 06/21/2007 | US20070142288 Isolated MCPIP and methods of use |
| 06/21/2007 | US20070142287 Compositions And Methods For Treatment Of Cancer |
| 06/21/2007 | US20070142286 Methods of treating fibrosing diseases by induction of immune tolerance |
| 06/21/2007 | US20070142285 Methods of Treatment and Uses for CaMKII and Its Interaction with HDACs and Calpain |
| 06/21/2007 | US20070142284 Vascular endothelial cell growth factor variants and uses thereof |
| 06/21/2007 | US20070142283 Angiogenically effective unit dose of FGF-2 and method of use |
| 06/21/2007 | US20070142281 Preventives/remedies for myeloma tumor and method for diagnosing the same |
| 06/21/2007 | US20070142280 Factor VII or VIIa-like molecules |
| 06/21/2007 | US20070142279 Agent for promoting induction of vascular differentiation, comprising hepatocyte growth factor |
| 06/21/2007 | US20070142278 Muteins of fibroblast growth factor 21 |
| 06/21/2007 | US20070142277 Bace455, an alternative splice variant of the human beta-secretase |
| 06/21/2007 | US20070142276 Protein involved in carcinoma |
| 06/21/2007 | US20070142275 for the treatment of diseases and pathological alterations associated with excessive or deregulated TGF- beta 1 expression |
| 06/21/2007 | US20070142274 Fish protein hydrolyzate |
| 06/21/2007 | US20070142273 Methods and compositions targeting tyrosine kinases for the diagnosis and treatment of osteoarthritis |
| 06/21/2007 | US20070142272 Neuroprotective activity of activated protein c independent of its anticoagulant activity |
| 06/21/2007 | US20070142271 Mracs as modifiers of the rac pathway and methods of use |
| 06/21/2007 | US20070142270 Aryl Sulfonic Pyridoxines as Antiplatelet Agents |
| 06/21/2007 | US20070142269 Neutrophil activating protein oligopeptides as medicaments for the treatment of Alzheimer's disease, Parkinson's disease, stroke, or cognitive impairment resulting from neural intoxication, neural injury, spinal injury |
| 06/21/2007 | US20070142268 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
| 06/21/2007 | US20070142267 Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 06/21/2007 | US20070142266 Combination comprising a P-gp inhibitor and an anti-epileptic drug |
| 06/21/2007 | US20070141704 Cell fusions and methods of making and using the same |
| 06/21/2007 | US20070141677 Genetic immunization with cationic lipids |
| 06/21/2007 | US20070141671 canine interleukin -5 protein for use in identifying immunomodulators which treat or prevent autoimmune, allergic, infectious, inflammatory and graft rejection disorders in animals |
| 06/21/2007 | US20070141669 Pregnancy-associated plasma protein-A2 (PAPP-A2) |
| 06/21/2007 | US20070141665 Chimeric protein for the screening of agonists and antagonists of cell signalling pathways that are dependent on g-protein-coupled receptors |
| 06/21/2007 | US20070141662 Fusion proteins and methods of cleavage of such proteins |
| 06/21/2007 | US20070141638 BGT1 transporters expressed in blood brain barrier cells |
| 06/21/2007 | US20070141620 Producing polyoxyethylene glycol covalently bound to human interferon; antiinflammatory and antitumor agents; autoimmune diseases and infections; conjugation decreases the number of doses for an intended effect, simplify and stabilize the formulation of a composition |
| 06/21/2007 | US20070141619 Drug resistance-associated gene and use thereof |
| 06/21/2007 | US20070141590 Modulators of tissue regeneration |
| 06/21/2007 | US20070141579 MUM-1 protein expressed by multiple myeloma-related gene |
| 06/21/2007 | US20070141573 Complement inhibitors |
| 06/21/2007 | US20070141569 Splice variant of human placental growth hormone |
| 06/21/2007 | US20070141183 tetrahydroisohumulone and dihydro-isohumulone coadministration; antiinflammatory; for treatment of diabetes |
| 06/21/2007 | US20070141145 Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
| 06/21/2007 | US20070141139 Composition for intestinal delivery |
| 06/21/2007 | US20070141136 intravenously administering to mammal a therapeutically effective amount of a liposomal suspension of small unilamellar vesicles (SUVs), wherein SUVs predominantly comprise phospholipids selected from phosphatidycholine, phosphatidylglycerol and phosphatidylserine |
| 06/21/2007 | US20070141135 Compositions and methods for less immunogenic protein-lipid complexes |
| 06/21/2007 | US20070141133 Liposomes; analgesics; glutathione is covalently bound to polyethylene glycol,wherein the polyethylene glycol is covalently bound to vitamin E or a phospholipid |
| 06/21/2007 | US20070141132 Human growth hormone patch formulations |
| 06/21/2007 | US20070141128 Wound cleansing apparatus with actives |
| 06/21/2007 | US20070141120 Peptide having an ace inhibiting effect |
| 06/21/2007 | US20070141103 Pliable medical device and method of use |
| 06/21/2007 | US20070141101 Method for stimulating angiogenesis and wound healing |
| 06/21/2007 | US20070141088 Glucan-based vaccines |
| 06/21/2007 | US20070141087 Compounds and methods for diagnosis of tuberculosis |
| 06/21/2007 | US20070141080 Treating severe acute respiratory syndrome |
| 06/21/2007 | US20070141072 Use of multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes |
| 06/21/2007 | US20070141069 Method for use of IGF-binding protein for selective sensitization of target cells in vivo |
| 06/21/2007 | US20070141063 Peptide having ability to activate cancer-related gene |
| 06/21/2007 | US20070141059 Use of cathepsin s inhibitors for treating an immune response caused by administration of a small molecule therapeutic or biologic |
| 06/21/2007 | US20070141057 Anti-TNF antibodies and peptides of human tumor necrosis factor |